/Investor DB

BIOSPRING PARTNERS

Growth equityActively deployingoperating company · company profile

New York · Growth · 22 people tracked

Also known as BIOSPRING MANAGEMENT, LLC

Find your way into BIOSPRING PARTNERS

Sign up to see every warm intro you have to BIOSPRING PARTNERS

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BIOSPRING PARTNERS team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Biospring Partners invests in technology-enabled, EBITDA-positive pharma services companies, aiming to build enduring businesses in the life sciences sector. It concentrates on three themes: outsourced complex biomanufacturing (biologics, bioconjugates, cell therapies, and peptides), outsourced clinical trial services (site operations, patient recruitment, participant access, and purpose-built technology), and digital transformation across the pharma value chain. Portfolio companies manufacture and support the supply chain for complex medicines and modernize clinical trial workflows, serving the life sciences industry and patients.

Source: firm website, verified Sep 29, 2026.

Stage
Growth
HQ
New York, New York, US
Instruments
Equity
Founded
2020
AUM
$245M
VC funds
9
Tracked investments
11

Team · 22 people

from the firm's website & curated & public directories
Ben Morss· Operations Associatein
Bob Pozen· Advisorin

Former Chair of MFS and former President of Fidelity Investments.

Brian Malone· Executive Vice President, Finance
David Mauney· Senior Advisorin

Former Managing Director at Koch Disruptive Technologies.

Jeff Bullock· Chief Financial Officerin
John Baldoni· Advisor

Former EVP of R&D at GSK.

John Bell· Senior Advisor

Former Regius Chair of Medicine at the University of Oxford.

John Sexton· Advisor

President Emeritus of New York University.

Peter Henry· Advisor

Senior Fellow at the Hoover Institution.

Precious Brown· Office Managerin
Qi Wang· Advisor

CIO of Portfolio Implementation at PIMCO.

Founder mafia

2 people who came through BIOSPRING PARTNERS went on to found or lead other companies.

What they invest in

from 8 of 11 portfolio companies

Biotech ×6Healthtech ×6Medical Devices ×4AI & Machine Learning ×3Deep Tech ×2Digital Health ×2SaaS ×2Advanced Manufacturing ×1

HQs:United States×5Switzerland×1

Investments · 11 tracked

founders shown can be your intro path

By year:2025 · 12023 · 32022 · 12021 · 27 dated

Kinicitikiniciti.cominNov 2021✓ verified

Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services.

BiotechDeep TechHealthtechMedical Devices

Geoffrey Glass(Founding CEO)in

Co-investorsWelsh, Carson, Anderson & StoweWCAS

Labvivalabviva.cominSeries A · Jan 2025 · $25M✓ verified

Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs.

AI & Machine LearningBiotechEnterprise SoftwareSaaSCambridge, US

Siamak Baharloo(Executive Officer, Director)inCarlo(GM of Europe)inNick Premnath(SVP of Commercial Strategy)inAaron Miramontes(Executive Officer)Nicholas Rioux(Executive Officer, Director)in

BoardSarah Fay(Director)in

Co-investorsGlasswing VenturesVillage Global53 StationsB Capital GroupB4 CapitalMassVentures

Abzenaabzena.comin𝕏Mar 2022 · $65M

Abzena is an integrated CDMO and CRO providing end-to-end development and cGMP manufacturing services for complex biologics and bioconjugates, including ADCs, AOCs, bispecifics, and HPAPIs.

Advanced ManufacturingBiotechHealthtechMedical DevicesCambridge, US

William John Edward Burt(Executive Officer, Director)Nigel Pitchford(Director)Leigh Pierce(Executive Officer)Kenneth Cunningham(Director)Julian Smith(Executive Officer, Director)Anthony Brampton(Director)

Co-investorsBeringeaWCASWelsh, Carson, Anderson & Stowe

Cedarhealthresearchcedarhealthresearch.comin𝕏

Cedar Health Research operates clinical research services for community-based healthcare providers, connecting patient populations with clinical trials through partnerships and EMR abstraction technology.

BiotechHealthtechMedical DevicesDallas, US

Mimi Fenton(Chief Executive Officer)

Cenexelcenexelresearch.com

CenExel operates a network of clinical research centers that conduct trials and studies to advance new medical treatments.

BiotechHealthtechMedical Devices

Co-investorsBayPineOwl Rock Capital

Ixlayerixlayer.comin𝕏Series A · Mar 2021 · $75M

ixlayer provides a platform that connects biopharma companies with patients, labs, providers, and payment systems to deploy personalized patient experience programs powered by AI.

AI & Machine LearningDigital HealthHealthtechSaaS

Pouria Sanae(Founder)Poorya Sabounchi(Co-founder and Chief Operating Officer)

Co-investorsInitiate Venture PartnersNimble PartnersXYZ Venture CapitalGeneral CatalystMBX Capital

Path Aipathai.com

AI-powered pathology for improved patient outcomes

Boston, US

ANDREW BECK(Executive Officer, Director)inADITYA KHOSLA(Executive Officer, Director)Aditya Khosla(Founder)Andy Beck(Chief Executive Officer, Co-founder)

BoardMICHELLE DIPP(Director)STANLEY LAPIDUS(Director)in

Co-investors8VCFairhaven Capital PartnersGeneral CatalystHighsage VenturesMerck Global Health Innovation FundMSD Global Health Innovation Fund+6 more

Reasonerreasoner.comPre-Seed · Jun 2023

Reasoner analyzes thousands of human behavioral and psychological signals — including what people say, choose, value, and avoid — to identify patterns unique to each individual.

AI & Machine LearningDeep Tech

Co-investorsAlumni VenturesBoston Seed CapitalOperator Collective186 VenturesAccompliceBaseline Ventures+5 more

Rocheroche.com

Roche is a healthcare company that develops diagnostics and pharmaceuticals aimed at preventing, treating, and curing diseases.

BiotechDigital HealthHealthtechBasel, CH

Thomas Schinecker(CEO)in

Co-investorsAllen & CompanyAlphabetFirst Round CapitalGV (Google Ventures)SV Angel

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

InfringementsInvalidate

Fund performance · per public LP disclosures · 2

as of Dec 2024
FundVintageCommittedNet IRRTVPIDPI
Biospring Partners Fund IILPs: Texas Municipal Retirement System, Los Angeles City Employees' Retirement System2024——0.00x—
Biospring Partners FundLPs: Los Angeles City Employees' Retirement System2020—7.8%13.62x6.82x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

How many investments has BIOSPRING PARTNERS made?
BIOSPRING PARTNERS has 11 tracked investments, including 1 dated in the last 24 months.
What stage does BIOSPRING PARTNERS invest at?
BIOSPRING PARTNERS invests at the Growth stage.
What sectors does BIOSPRING PARTNERS focus on?
BIOSPRING PARTNERS focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS.
Where is BIOSPRING PARTNERS located?
BIOSPRING PARTNERS is headquartered in New York, US.
Who does BIOSPRING PARTNERS co-invest with?
BIOSPRING PARTNERS most often shares deals with Nimble Partners, WCAS, 8VC, among 21 tracked co-investors.

Images

BIOSPRING PARTNERS photoBIOSPRING PARTNERS photoBIOSPRING PARTNERS photo

Co-investors · 56

NextView Ventures

NextView Ventures is a seed-stage venture capital firm that works closely with founders, providing hands-on support to help build companies from inception to scale.

Both backed · 3
ReasonerInfringementsInvalidate
$250K – $4M
Accomplice

Accomplice is a venture capital firm that has backed early-stage companies across sectors, having been part of the origin stories of companies like AngelList, DraftKings, Patreon and WHOOP.

Both backed · 3
ReasonerInfringementsInvalidate
$5M – $25M
NextGen Venture Partners

NextGen Venture Partners (NGVP) is an early-stage venture firm that leads seed investments in B2B startups, backing companies from seed to scale.

Both backed · 3
ReasonerInfringementsInvalidate
$500K – $2M
Baseline Ventures

Baseline Ventures is a pioneering "micro VC" firm structured as a one-man operation where Steve Anderson handles all sourcing, decision-making, and partnering himself, writing concentrated seed checks from small funds rather than using a traditional multi-partner platform. Despite being one of Silicon Valley's smallest investment firms, Baseline achieved outsized success with multiple billion-dollar outcomes including Instagram (where Anderson was the very first investor) through Anderson's fast, gut-based decision style that emphasizes founder quality over elaborate modeling.

Both backed · 3
ReasonerInfringementsInvalidate
$100K – $1M
VitalStage Ventures

VitalStage Ventures is a seed-stage investment firm run by former entrepreneurs and AI builders that backs founders innovating in AI infrastructure and applications.

Both backed · 3
ReasonerInfringementsInvalidate
186 Ventures

186 Ventures is an early-stage venture capital firm founded by former DraftKings operators, backing fast-growing founders and companies from the pre-seed and seed stages.

Both backed · 3
ReasonerInfringementsInvalidate
Impellent Ventures

Impellent Ventures is an operator-led venture firm backing preseed and seed-stage founders, writing checks up to $1.5M and aiming to be a company's first investor.

Both backed · 3
ReasonerInfringementsInvalidate
$1.5M
General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

Both backed · 2
Path AiIxlayer
$30M
B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

Both backed · 1
$10M – $50M
Village Global

Village Global is an early-stage venture capital firm that leads pre-seed and seed rounds globally and across sectors, backed by a network of prominent tech founders and operators who serve as LPs.

Both backed · 1
$500K – $3M
Glasswing Ventures

Glasswing Ventures is an early-stage venture capital firm that backs founders building enterprise and security solutions powered by AI and frontier technology.

Both backed · 1
$100K – $5M
Boston Seed Capital

Boston Seed Capital is a Boston-based venture firm that invests at the pre-seed and seed stages, backing technology-driven, consumer-focused and data-driven startups.

Both backed · 1
▶44 more co-investors

MBX CapitalBessemer Venture PartnersTechstarsFounder CollectiveBenchmarkUnknown VenturesMenlo VenturesBoxGroupPlug and Play VenturesGoat CapitalC2 InvestmentsObvious VenturesFlybridge Capital PartnersCota CapitalResolute VenturesStride VCNext4701 AdvisorsPolaris PartnersAtlas VenturePear VCUpfront VenturesBAM VenturesWGI GroupUnusual Ventures23andMeMoxxie VenturesTribeca Venture PartnersTransmedia CapitalProximity VenturesFounders' Co-opCapital FactoryAccelerator VenturesPropeller VCBDC Venture CapitalPredictive VCXfundG20 VenturesXSeed CapitalCambrian Asset ManagementKohala VenturesC2 VenturesData Point CapitalKain Capital

Firms observed investing alongside BIOSPRING PARTNERS, from public investor directories. Shared companies are the overlap with BIOSPRING PARTNERS's recorded portfolio.

Similar investors

Featured in lists